Liliana Doganova

Researcher, Associate professor

  • Presentation

Liliana Doganova’s research lies at the intersection of economic sociology and STS (Science and Technology Studies), and explores market construction processes and valuation devices.
Her work can be divided into three main themes: the valorization of public research; markets, valuation and controversies; the performativity of valuation devices (business models and plans, discounted cash flow and real options). For a presentation of published or current work on these themes, see below.
Liliana Doganova teaches at Ecole des Mines and PSL. She is member of the editorial boards of Revue d’Anthropologie des Connaissances and Valuation Studies. For a complete CV, see here.


The valorization of public research

Her initial research, conducted as part of her PhD thesis at the CSI, focused on the valorization of science and the creation of spin-offs from public research. It resulted in the publication of a book and two articles:

[2012] Valoriser la science. Les partenariats des start-up technologiques. (Valuing science. The partnerships of high-tech start-ups). Presses des Mines
[2013] Transfer and exploration: two models of science-industry intermediation. Science and Public Policy
[2015] Hybrid alliances and radical innovation: the performance implications of integrating exploration and exploitation. Journal of Technology Transfer (with M. Colombo, E. Piva, D. D’Adda, & P. Mustar)

Markets, valuation and controversies

As part of a post-doc at Copenhagen Business School, Liliana Doganova investigated clean-tech markets and social entrepreneurship. Her research in this field explores how, and with what effects, markets are proposed as solutions to political problems (pollution and poverty reduction) and resigned to integrate new valuation modes (environmental and social values).
[2015] Building markets for clean technologies: controversies, environmental concerns and economic worth. Industrial Marketing Management (with P. Karnoe)
[Forthcoming] Clean and profitable: entangling valuations in environmental entrepreneurship. In A. B. Antal, M. Hutter, & D. Stark (Eds.), Moments of Valuation: Exploring Sites of Dissonance. Oxford University Press (with P. Karnoe)
[Under review] Keeping things different: Coexistence within European markets for cleantech and biofuels. (with B. Laurent)
[In progress] A paper that explores social entrepreneurship, business model innovation and the construction of the entrepreneur, through a case study on the commercialization of a water access service in Kenya.

The performativity of valuation devices

Since her doctoral research, Liliana Doganova have been interested in valuation devices, such as models, calculation formulae and demonstrations. She explore their performativity by looking at how these tools come into being, and what effects they induce in practice.
Several papers examine the roles of business models and plans in entrepreneurship:
[2009] What do business models do? Innovation devices in technology entrepreneurship. Research Policy (with M. Eyquem-Renault)
[2015] Capitalization devices: business models and the renewal of markets. In M. Kornberger, L. Justesen, J. Mouritsen, & A. Koed Madsen (Eds.), Making Things Valuable. Oxford University Press (with F. Muniesa)
[Under review] Entrepreneurial formulas. Business plans and the formation of new ventures. (with M. Giraudeau)
Her current research, conducted as part of the PERFORMABUSINESS project, explores the history and use of two calculation formulae: discounted cash flow and real options.
[2014] Décompter le futur: la formule des flux actualisés et le manager-investisseur. ((De)valuing the Future: The Discounted Cash Flow Formula and the Investing Manager). Sociétés Contemporaines
[2015] Que vaut une molécule ? Formulation de la valeur dans les projets de développement de nouveaux médicaments. (What’s a molecule worth ? The formulation of value in drug development projects)
Another work in progress examines “partnering conferences” as a peculiar form of demonstration in the biotech industry.


Latest publications


* According summaries present in the bibliographic database